|
1. |
Protecting the Residual Renal Function: How Do ACE Inhibitors and Calcium Antagonists Compare? |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 257-262
Giuseppe Maschio,
Preview
|
PDF (1163KB)
|
|
ISSN:1660-8151
DOI:10.1159/000187976
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
2. |
Should We Continue to Recommend that a Deficit of KCI Be Treated with NaCI? |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 263-269
Mitchell L. Halperin,
Adrienne Scheich,
Preview
|
PDF (1347KB)
|
|
ISSN:1660-8151
DOI:10.1159/000187977
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
3. |
Thalidomide for the Treatment of Uremic Pruritus: A Crossover Randomized Double-Blind Trial |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 270-273
Sandra R.B. Silva,
Pedro C.F. Viana,
Nilza V. Lugon,
Marcos Hoette,
Frederico Ruzany,
Jocemir R. Lugon,
Preview
|
PDF (780KB)
|
|
摘要:
Our observation that thalidomide administration to a dialysis patient with leprosy alleviated his pruritus led us to condut this short-term study to assess the efficacy of the drug in this regard. From 210 hemodialysis patients, 29 cases of refractory uremic pruritus were entered into the study. Patients were instructed to score their symptoms from 0 to 3, three times a day and assigned to receive thalidomide or placebo at bed time for 7 days. After a washout period of 7 days, drugs were crossed over. Response was defined as a reduction of at least 50% in the pruritus scoring. Eigtheen patients finished the study. In the first phase, 55% of patients responded showing a mean reduction in their pruritus scoring of 78% (p < 0.05 vs. placebo); no response to placebo was observed. A similar proportion of patients responded to thalidomide in the second phase with a mean reduction in their pruritus scoring of 81%. In conclusion, thalidomide can be a precious tool in the handling of uremic pruritus unresponsive to available therapy.
ISSN:1660-8151
DOI:10.1159/000187978
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
4. |
Clinical Value of DMSA Planar and Single Photon Emission Computed Tomography as an Initial Diagnostic Tool in Adult Women with Recurrent Acute Pyelonephritis |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 274-279
Soon.Bae Kim,
Won Seok Yang,
Jin Sook Ryu,
Jae Hoon Song,
Dae Hyuk Moon,
Kyung Sik Cho,
Jung Sik Park,
Changgi D. Hong,
Preview
|
PDF (1070KB)
|
|
摘要:
Routine DMSA scintigraphy, ultrasound (US) of the kidney, intravenous pyelography (IVP) and voiding cystoureterography (VCU) were performed in 27 consecutive adult women with recurrent acute pyelonephritis (APN) during a 12-month follow-up. Both planar and single photon emission computed tomography (SPECT) images were obtained for DMSA scan. DMSA scans were repeated in those patients with abnormal initial scan. DMSA-SPECT showed normal findings in 2, single renal cortical detect (RCD) in 9 and multiple RCD in 16 (including nonvisualization in 2). Of the 11 kidneys with normal findings or single RCD on DMSA-SPECT, only 1 (9%) showed vesicoureteral reflux (VUR) on VCU (grade I). A large proportion of those with multiple RCDs showed abnormal findings on IVP (44%, 7/16), US (38%, 6/16) or VCU (31%, 5/16); 63% in any of these three studies. 5 of 6 patients with VUR had multiple RCDs on DMSA-SPECT, and 3 of these 5 showed no abnormality on IVP or US. 7 patients who needed other managements besides initial standard antibiotic treatment had multiple RCDs on DMSA-SPECT. 15 normal women were also studied and showed normal DMSA-SPECT, US and IVP, in all cases. Follow-up DMSA-SPECT was done in 16 patients (7 with single RCD, 9 with multiple RCD). All 7 patients with single RCD showed improvement, in those with multiple RCDs improvement was observed in 2, no change in 7 on follow-up studies. We conclude: (1) DMSA-SPECT is a useful initial diagnostic tool in adult women with recurrent APN to identify patients who need more extensive radiological studies. (2) The multiple RCDs on DMSA-SPECT indicate irreversible tissue damage in most adult women with recurrent APN.
ISSN:1660-8151
DOI:10.1159/000187979
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
5. |
Determination of Kt/V and Protein Catabolic Rate Using Pre- and Postdialysis Blood Urea Nitrogen Concentrations |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 280-290
Toru Shinzato,
Shigeru Nakai,
Yoshiro Fujita,
Ichiro Takai,
Eiroyuki Morita,
Kazunori Nakane,
Kenji Maeda,
Preview
|
PDF (1920KB)
|
|
摘要:
We developed a new urea kinetic method for simultaneous determination of the Kt/V and protein catabolic rate (PCR) only from blood urea nitrogen (BUN) concentrations before and after a single dialysis session. Using this method, the parameters were calculated within 1.5 s even when a hand-held computer with a low central processing capacity is used. The total amount of urea eliminated during three dialysis sessions in 1 week is assumed to be equal to urea volume (Gw) generated over a 1-week period (Tw): Gw = G × Tw = K T∫0 C1dt+ T∫0 C2dt+ T∫0 C3dt). Here, G is the generation rate, K is the dialyzer urea clearance, T is the dialysis time and Q, C2 and C3 are BUN during the respective dialysis session. If this equation and the equation expressing the urea kinetics during a single dialysis session are solved together, we have a solution for Kt/V and G. The thus-obtained Kt/V and G are corrected using the change in body weight. The corrected Kt/V showed a good correspondence with the parameter calculated with the classical method, and the midweek PCR derived from G determined by the present method being equivalent to the PCR averaged for a 1-week period determined by the classical m
ISSN:1660-8151
DOI:10.1159/000187980
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
6. |
Influence of Azathioprine on the Ferrokinetics of Patients with Renal Failure before and after Treatment with Erythropoietin |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 291-296
E. Anastassiades,
D. Howarth,
J.E. Howarth,
D. Shanks,
H.M. Waters,
K. Hyde,
J.A. Liu Yin,
C.G. Geary,
R. Gokal,
Preview
|
PDF (1204KB)
|
|
摘要:
In 16 patients (9 on azathioprine, 7 not) the ineffective iron turnover (I IT) was much higher in the azathioprine group (62.7 ± 6.7 vs. 23.5 ± 3.5 μmol/l blood/ day, p < 0.0001, 2-tailed t test), though the red cell iron turnover (ROT) was similar (42.8 ± 2.9 vs. 41 ± 4.8). Erythropoietin improved the anaemia in all patients and raised the RCIT (4 still on azathioprine to 72.2 ± 9.8, p < 0.003; 7 non-azathioprine patients to 62.7 ± 5.3, p < 0.01); the ΠT remained higher in the azathioprine-treated (85.5 ± 19.3 vs. 37.1 ± 5.4; p < 0.013). In 2 patients who discontinued azathioprine, the IIT declined markedly to normal. In summary, azathioprine exacerbates the anaemia of renal failure by augmenting ineffective erythropoiesis, while erythropoietin benefits those on azathioprine as much as other renal patients by stimulating both effective and ineffective eryth
ISSN:1660-8151
DOI:10.1159/000187981
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
7. |
Increased Serum Erythropoietin Level during Azathioprine Treatment in Renal Transplant Recipients |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 297-301
Jens D. Jensen,
Hans E. Hansen,
Erling B. Pedersen,
Preview
|
PDF (988KB)
|
|
摘要:
One hundred and six renal transplant patients were studied. During the first 12 months after renal transplantation all patients were treated with cyclosporine (Cy) and prednisone. At 12 months after transplantation the patients were randomly allocated to either conventional treatment with azathioprine (Az) and prednisone (group Az) or to continued treatment with Cy and prednisone (group Cy). Serum erythropoietin (s-EPO), glomerular filtration rate (GFR) and hematocrit (Hct) were measured at 12,18 and 24 months after transplantation. s-EPO rose in the group Az from 19 U/l (mean) at 12 months to 28 U/l (p < 0.01) at 18 months and remained elevated at 24 months at 29 U/l compared with baseline level and with healthy subjects without anemia 18 U/l (p < 0.01). There was no significant change in s-EPO in group Cy during the study. The Hct in the two groups was not significantly different. GFR was the same in the two groups at 12 months and after 24 months. In conclusion, a switch from Cy to Az 1 year after renal transplantation results in a sustained rise in s-EPO which may in part represent a compensatory phenomenon to bone marrow suppression.
ISSN:1660-8151
DOI:10.1159/000187982
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
8. |
Announcement |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 301-301
Preview
|
PDF (164KB)
|
|
ISSN:1660-8151
DOI:10.1159/000187983
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
9. |
Expression of Intercellular Adhesion Molecule-1 and Infiltration of Lymphocytes in Glomeruli of Patients with IgA Nephropathy |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 302-307
Yasuhiko Tomino,
Hiroyuki Ohmuro,
Takao Kuramoto,
Isao Shirato,
Kazuhiko Eguchi,
Hideto Sakai,
Ko Okumura,
Hikaru Koide,
Preview
|
PDF (1206KB)
|
|
摘要:
Using immunofluorescence, we studied 19 patients with IgA nephropathy to determine whether the expression of intercellular adhesion molecule (ICAM)-l in glomeruli might reflect the disease activity. The relationship between the expression of ICAM-1 and the infiltration of lymphocytes, monocytes and polymorphonuclear leukocytes (PMN) in glomeruli of IgA nephropathy cases was examined. The expression of IC AM-1 in patients in the advanced stage was significantly higher than that in patients in the mild stage. In double immunofluorescence, the distribution of ICAM-1 expression in glomeruli was different from that of IgA deposition in patients in both stages. Glomeruli which showed increases of ICAM-1 expression had marked infiltration of lymphocytes (OKT4+, OKT8+ T cells), and monocytes (OKM1+ cells). Increase of urinary protein and decreases in renal function were observed in patients in the advanced stage. It appears that the expression of ICAM-1 is closely linked to glomerular cell proliferation, and infiltration of lymphocytes and monocytes in patients with IgA nephropathy. However, the expression of ICAM-1 in glomeruli might not be correlated with IgA-dominant immune complexes in this disease.
ISSN:1660-8151
DOI:10.1159/000187984
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
10. |
Urinary π-Class Glutathione Transferase as an Indicator of Tubular Damage in the Human Kidney |
|
Nephron,
Volume 67,
Issue 3,
1994,
Page 308-316
Anders G.M. Sundberg,
Eeva-Liisa Appelkvist,
Lars Bäckman,
Gustav Dallner,
Preview
|
PDF (1725KB)
|
|
摘要:
Glutathione transferase-π released from kidney tubular epithelial cells was analyzed in the urine of recipients of renal allografts. Urinary content of α -class glutathione transferase was also determined for comparison. Control urine from healthy individuals contained detectable levels of the π-isoenzyme (6.6 ± 0.46 ng/ml, mean ± SEM) and this concentration was not increased in the urine of patients demonstrating cyclosporine A-induced nephrotoxicity (6.3 ± 0.29 ng/ml), in contrast to the < -form. Acute rejection increased excretion of the π-isoenzyme (19.0 ± 2.0 ng/ml), but not of the α-glutathione transferase. Thus, while the serum creatinine level increases in connection with both cyclosporine A-induced nephrotoxicity and acute rejection, analyses of urinary glutathione transferases distinguish well between these conditions. Acute tubular necrosis and renal transplant infarction resulted in a rapid elevation in urinary levels of both α – andπ-transferase. The advantages of this approach are that release of the protein into the urine occurs rapidly after tubular damage, the assay is sensitive and specific and can also distinguish between certain pathological conditions. These studies thus indicate that the urinary level of glutathione transferase-α can be used for monitoring certain pathological processes in the kidney. Quantitation of this enzyme complements the information obtained by measurement of glutathione transfera
ISSN:1660-8151
DOI:10.1159/000187985
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
|